<DOC>
	<DOCNO>NCT02348073</DOCNO>
	<brief_summary>Our project aim develop new therapeutic approach epilepsy-associated attention disorder child , evaluation clinical impact dietary n-3 fatty acid , contain eicosapentaenoic acid ( EPA ) docosahexaenoic acid ( DHA ) conjugate phospholipid vector . The primary objective evaluate efficacy PUFA supplementation ( PS-Omega 3 ) , 12 week treatment , attention disorder child epilepsy . Secondary objective include : - To evaluate impact supplementation PS-Omega 3 quality life . - To evaluate impact supplementation PS-Omega 3 serum erythrocyte lipid profile . - To assess tolerance supplementation PS-Omega 3 . - To assess impact supplementation PS-Omega 3 frequency seizure . - To describe impact supplementation PS-Omega 3 , 24 week , 1. attention disorder child epilepsy , 2. quality life , 3. serum erythrocyte lipid profile . This study recruit 272 subject age 6- 16 year , suffer epilepsy ( type ) attention deficit hyperactivity disorder ( ADHD ) ( inattentive combine type ) accord DSM V criterion 12 clinical site France .</brief_summary>
	<brief_title>Efficacy Phosphatidylserine Enriched With n-3 PUFA Supplementation ADHD Children With Epilepsy</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<criteria>Children age 6 15 year 11 month . Children either sex ( male/female ) suffer epilepsy regardless syndrome classification . Subjects stable dose antiepileptic drug ( AED ) least one month prior inclusion subject change consider priori three month follow inclusion . Diagnosis ADHD inattention mix type accord DSM IV criterion . Subjects must agree study participation parents/legal guardian must provide write inform consent prior participation study . Subjects less 6 year old 16 year old AED stable least one month and/or change AED expect three month follow inclusion . Diagnosis ADHD hyperactivity type exclusive accord DSM V criterion . Mental retardation define score &lt; 70 verbal comprehension perceptual reason Wechsler Intelligence Scale Children Fourth Edition ( WISCIV ) . Diagnosis psychiatric comorbidity ADHD accord DSM IV criterion , include : pervasive developmental disorder include autism disorder ; bipolar disordersand psychotic disorder . Children suffer diabetes , type . Use psychoactive drug ADHD within previous month : Methylphenidate , Amphetamine , Atomoxetine , Modafinil Antidepressants whatever class . Use dietary supplementation , vitamin , within last 3 month . Use ketogenic diet within last 3 month . Allergy fish sea product . Soy allergy . Absence coverage social security .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>Attention Deficit Disorders</keyword>
	<keyword>VAYARIN</keyword>
	<keyword>Children</keyword>
	<keyword>Polyunsaturated n-3 fatty acid supplementation</keyword>
</DOC>